Displaying One Session

View
ESMO Colloquium Auditorium 113

ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy

Date
Thu, 23.02.2023
Time
18:00 - 19:00
Room
Auditorium 113
Chairs
  • Vicky Makker (New York City, NY, United States of America)
  • Alexandra Leary (Villejuif, France)
Session Description

Access the COLLOQUIUM EVALUATION FORM

ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy ESMO Colloquium

Introduction

Lecture Time
18:00 - 18:05
Speakers
  • Vicky Makker (New York City, NY, United States of America)
Session Name
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
18:00 - 19:00
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy ESMO Colloquium

Emerging molecular profiling models for advanced endometrial cancer: Prognosticators and predictors of benefit from IO and targeted therapeutics

Lecture Time
18:05 - 18:20
Speakers
  • Tjalling Bosse (Leiden, Netherlands)
Session Name
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
18:00 - 19:00
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy ESMO Colloquium

The landscape of approved immune checkpoint inhibitors and TKI combinations in advanced endometrial cancer

Lecture Time
18:20 - 18:35
Speakers
  • Vicky Makker (New York City, NY, United States of America)
Session Name
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
18:00 - 19:00
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy ESMO Colloquium

Research insights: New immunotherapy combinations in clinical development for gynecological malignancies

Lecture Time
18:35 - 18:50
Speakers
  • Alexandra Leary (Villejuif, France)
Session Name
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
18:00 - 19:00
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy ESMO Colloquium

Q&A

Lecture Time
18:50 - 18:55
Speakers
  • All Speakers (Barcelona, Spain)
Session Name
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
18:00 - 19:00
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy ESMO Colloquium

Concluding remarks

Lecture Time
18:55 - 19:00
Speakers
  • Alexandra Leary (Villejuif, France)
Session Name
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
18:00 - 19:00